Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Lamictal TM Augmentation of Haloperidol Decanoate in the Treatment of Resistant Schizophrenia Predominantly by Verbal Resistant Hallucinosis: Randomized, Double-blind, Placebo-controlled, Study

NCT00947375 is registered in ClinicalTrials.gov with Central Mental Clinic for Outpatients of Baku City as lead sponsor.

NCT NCT00947375
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00947375 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Lamictal TM Augmentation of Haloperidol Decanoate in the Treatment of Resistant Schizophrenia Predominantly by Verbal Resistant Hallucinosis: Randomized, Double-blind, Placebo-controlled, Study
Lead sponsor
Central Mental Clinic for Outpatients of Baku City
Phase
Phase 4
Overall status
Terminated
Start date
January 31, 2005
Completion date
January 31, 2007
Enrollment
335 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia